Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2017-06-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Data Analysis of Data From the Zurich PH Registry
NCT03198910
Zürich Pulmonary Hypertension Outcome Assessment Cohort
NCT02249806
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
NCT00370214
Latin American Pulmonary Hypertension Registry
NCT02570737
Pulmonary Hypertension--Mechanisms and Family Registry
NCT00005357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary arterial hypertension
Pulmonary arterial hypertension
No interventions assigned to this group
PH due to left heart diseases
PH due to left heart diseases
No interventions assigned to this group
PH due to lung disease and/or hypoxia
PH due to lung disease and/or hypoxia
No interventions assigned to this group
Chronic thromboembolic PH
Chronic thromboembolic PH
No interventions assigned to this group
Miscellaneous PH
Miscellaneous PH
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Actelion
INDUSTRY
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Ulrich, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
UniversityHospital Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Respiratory Clinic, University Hospital of Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Swiss PH Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.